Tech billionaire and Twitter’s CEO, Elon Musk, has disclosed that Neuralink has received approval from the Food and Drug Administration (FDA) USA to conduct its first clinical trial of implanting microchips in humans.
The CEO made this known on Twitter, with the caption, “Congratulations Neuralink team! Elon Musk”.
Elon Musk’s company excited In a tweet, Neuralink expressed excitement about the FDA’s approval, stating that it is a crucial first step toward helping many people.
However, the specifics of the approved trial have not been disclosed, and patient recruitment has not yet begun.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.
“Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!”.
Neuralink, which aims to develop brain implants that can decode neural signals and connect them to computers. This is to assist patients with severe paralysis in controlling external technologies solely using neural signals.
– (FACEBOOK | NEURALINK)
Leave a Reply